Functional observation after morphine withdrawal: effects of SJP-005

RATIONALE AND OBJECTIVE: SJP-005 (ketotifen and ibuprofen) is being developed as a potential new treatment for opioid withdrawal. Three studies were conducted to evaluate the early phase (acute, day 1) and late phase (days 2–12) effects of SJP-005 on discontinuation-induced morphine withdrawal. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Verster, Joris C., Scholey, Andrew, Dahl, Thomas A., Iversen, Jacqueline M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139893/
https://www.ncbi.nlm.nih.gov/pubmed/33555386
http://dx.doi.org/10.1007/s00213-021-05771-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139893/
https://www.ncbi.nlm.nih.gov/pubmed/33555386
http://dx.doi.org/10.1007/s00213-021-05771-5

Ejemplares similares